Ledger.Open graph →
SEC Form D · Amendment · filed February 23, 2018

BTG PLC

Offering
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LONDON, United Kingdom
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Paul Mussenden · London, United KingdomExecGiles Kerr · London, United KingdomDirectorJim O'Shea · London, United KingdomDirectorDuncan Kennedy · London, United KingdomExec · DirectorRichard Wohanka · London, United KingdomDirectorAnne Thorburn · London, United KingdomDirectorIan Much · London, United KingdomDirectorGarry Watts · London, United KingdomDirectorSusan Foden · London, United KingdomDirectorGraham Hetherington · London, United KingdomDirectorLouise Makin · London, United KingdomExec · DirectorGregory Barrett · London, United KingdomDirectorGeneral Partner of the General Partner Charlesbank Credit Opportunities Fund II GP, LLC · Boston, MADirectorSole Member of the General Partner of the General Partner Charlesbank Capital Partners, LLC · Boston, MADirectorBrett A. Hickey · New York, NYExecZack T. Sledge · MIDLAND, TXDirectorSudhir Krishnamurthi · Washington, Washington, D.C.DirectorCharlesbank Credit Opportunities Fund II GP, Limited Partnership · Boston, MAExec · DirectorStephen T. Goree · MIDLAND, TXDirectorAfsaneh Beschloss · Washington, Washington, D.C.Exec · DirectorTruman N. Morris, Jr · Austin, TXExec · DirectorGary Appel · New York, NYDirectorClinton P. Bybee · San Francisco, CAExec · DirectorMichel J. Maloof · San Francisco, CADirectorBrett Montana · Austin, TXDirectorLeighton J. Read · San Francisco, CADirectorAli D. Rezai · Redwood City, CADirectorJuanita Thomas · Oldsmar, FLDirectorVinay Awati · Schaumburg, ILDirectorLisa Swartzman · Mississauga, Ontario, CanadaDirectorCraig Collard · Mississauga, Ontario, CanadaExec · DirectorRichard Mavrinac · Mississauga, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗